Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Becton Dickinson Introduces the MICROTAINER -R- Brand GENIE -TM- Lancet; A New Safety-Engineered Product to Protect Health Care Workers From Accidental Injury.


FRANKLIN LAKES, NJ--(BW HealthWire)--May 12, 1999--

BD (NYSE NYSE

See: New York Stock Exchange
: BDX BDX Bordeaux (France)
BDX Becton-Dickinson and Company (stock symbol)
BDX Business Document Exchange
BDX Burst Detector X
BDX Beacon Data Extractor
) today announced the launch of the MICROTAINER(R) Brand GENIE(TM) lancet lancet /lan·cet/ (lan´set) a small, pointed, two-edged surgical knife.

lan·cet
n.
, a single-use capillary capillary (kăp`əlĕr'ē), microscopic blood vessel, smallest unit of the circulatory system. Capillaries form a network of tiny tubes throughout the body, connecting arterioles (smallest arteries) and venules (smallest veins).  blood sampling device. The latest in a long line of BD products with safety-engineered features, the GENIE lancet's advanced design technology provides automatic and permanent blade retraction In the law of Defamation, a formal recanting of the libelous or slanderous material.

Retraction is not a defense to defamation, but under certain circumstances, it is admissible in Mitigation of Damages. Cross-references

Libel and Slander.
, minimizing the possibility of injury and reuse reuse - Using code developed for one application program in another application. Traditionally achieved using program libraries. Object-oriented programming offers reusability of code via its techniques of inheritance and genericity. .

"BD is proud to add the GENIE lancet to our long line of safety-engineered products," said Richard Brajer, President, Worldwide Sample Collection at BD. "As BD continues to expand its array of safety-engineered products, we take particular pride in our ability to provide additional protection for health care workers and patients without compromising the standards of excellence in clinical performance that our customers have come to expect from BD."

Used for capillary blood sampling, a procedure commonly known as a "finger stick," the GENIE lancet offers precision, ease-of-use and enhanced protection to both clinician clinician /cli·ni·cian/ (kli-nish´in) an expert clinical physician and teacher.

cli·ni·cian
n.
 and patient. Each unit is entirely self-contained, with a small plastic tab protecting the sterile blade. When the protective tab is removed, the blade remains inaccessible until the user places the GENIE lancet against the puncture puncture /punc·ture/ (-cher) the act of piercing or penetrating with a pointed object or instrument; a wound so made.

cisternal puncture
 site on the pad of the finger; once the trigger is pressed, the sterile blade instantly punctures the skin to the required depth and springs back into its housing. The deployment and retraction of the blade occurs in a single action after which the blade is safely and permanently contained within the device. The GENIE lancet is offered in a full range of blade depths for sufficient blood volume in multiple sample requirements.

In October 1998, BD established the Advanced Protection Technology group to coordinate the development, production and marketing of all the Company's products with safety-engineered features. GENIE lancets are a key addition to this expanding array of medical devices, which now numbers over 200 products.

BD manufactures and sells a broad range of medical supplies, devices, and diagnostic systems for use by health care professionals, medical research institutions, and the general public.

This press release may contain certain forward-looking statements forward-looking statement

A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections.
 (as defined under Federal securities laws) regarding the company's performance, including future revenues, products and income, which are based upon current expectations of the company and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described in any forward-looking statement. Factors that could cause actual results to vary materially include, but are not limited to, competitive factors, changes in regional, national or foreign currency exchange rates, delays in product introductions, year 2000 issues, and changes in health care or other government regulations, as well as other factors discussed herein and in the company's filings with the Securities and Exchange Commission.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:May 12, 1999
Words:449
Previous Article:A&P Names Cheryl Palmer Senior Vice President Strategic Marketing; Addition of Marketing Expert Reinforces Leading Supermarket Chain's Commitment to...
Next Article:New Flights Available for Aruba's Summer Season; Air Aruba Boasts 28% Increase; Charters Added.
Topics:



Related Articles
Specialized Health Products International, Inc. Announces Clearance of its 510K Notification of Intent to Market its Latest Safety Cradle Product.
Specialized Health Products International, Inc. announces letter of intent with Becton Dickinson; agreement focuses on the commercialization of the...
Becton Dickinson Continues to Go Way Beyond Talk in Corporate Use of Web Technology.
Becton Dickinson Acquires New Advanced Protection Technology; Company Signs Licensing Agreement with Med-Design for Retractable Needle Technology.
Bio-Plexus Technology Featured On Dateline NBC.
Federal Safety Needle Legislation.
Becton Dickinson Announces National Agreement With Kaiser Permanente.
Shot in the arm.
IN BRIEF.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles